Market Currents
ShangPharma (SHP -2.4%) slips after missing on its Q2 results earlier today. The company also...
-
Monday, August 20, 2012, 12:23 PM ETShangPharma (SHP -2.4%) slips after missing on its Q2 results earlier today. The company also reconfirms its guidance for net revenues for FY12. Net revenues are expected to be approximately $131.7 to $136.2 million, which represents growth of approximately 18% to 22% compared with FY11. William Blair cuts the shares to Market Perform on the report.
Other date
Latest Earnings Articles
